Voyager Therapeutics VYGR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 4.67 | -0.47 | -30,594 | -28 | ||
| 2025Q2 | 3.11 | -0.57 | -36,625 | -33 | ||
| 2025Q1 | 3.38 | 111.97 | -0.53 | -34,693 | -31 | |
| 2024Q4 | 5.67 | 112.97 | 11.97 | -0.60 | -38,299 | -34 |
| 2024Q3 | 5.85 | 153.09 | 35.36 | -0.16 | -13,780 | -9 |
| 2024Q2 | 7.91 | 148.51 | -0.17 | -15,025 | -10 | |
| 2024Q1 | 9.31 | 143.01 | 3.82 | -0.20 | -16,183 | -11 |
| 2023Q4 | 8.44 | 118.83 | 7.10 | 1.19 | 54,063 | 56 |
| 2023Q3 | 7.75 | 113.15 | 3.55 | -0.55 | -29,507 | -26 |
| 2023Q2 | 11.45 | 114.80 | 5.04 | -0.61 | -25,426 | -22 |
| 2023Q1 | 7.71 | 98.51 | 2.94 | 122,884 | 124 | |
| 2022Q4 | 6.10 | -0.61 | -24,563 | -24 | ||
| 2022Q3 | 5.92 | 81.95 | 0.47 | 14,442 | 18 | |
| 2022Q2 | 5.91 | 101.46 | -0.50 | -19,366 | -19 | |
| 2022Q1 | 7.62 | 100.15 | -0.56 | -21,350 | -21 | |
| 2021Q4 | 2.71 | 93.49 | 0.15 | 5,702 | 6 | |
| 2021Q3 | 2.63 | 100.04 | 5.57 | -0.66 | -25,146 | -25 |
| 2021Q2 | 4.13 | 94.90 | 3.96 | -0.80 | -28,585 | -30 |
| 2021Q1 | 4.71 | 118.20 | 4.83 | -0.58 | -25,589 | -22 |
| 2020Q4 | 7.15 | 149.00 | 6.68 | -0.42 | -23,729 | -16 |